Alterations of NMR-Based Lipoprotein Profile Distinguish Unstable Angina Patients with Different Severity of Coronary Lesions

Yongxin Ye, Jiahua Fan, Zhiteng Chen, Xiuwen Li, Maoxiong Wu, Wenhao Liu, Shiyi Zhou, Morten Arendt Rasmussen, Søren Balling Engelsen, Yangxin Chen, Bekzod Khakimov, Min Xia*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

1 Citationer (Scopus)
24 Downloads (Pure)

Abstract

Non-invasive detection of unstable angina (UA) patients with different severity of coronary lesions remains challenging. This study aimed to identify plasma lipoproteins (LPs) that can be used as potential biomarkers for assessing the severity of coronary lesions, determined by the Gensini score (GS), in UA patients. We collected blood plasma from 67 inpatients with angiographically normal coronary arteries (NCA) and 230 UA patients, 155 of them with lowGS (GS ≤ 25.4) and 75 with highGS (GS > 25.4), and analyzed it using proton nuclear magnetic resonance spectroscopy to quantify 112 lipoprotein variables. In a logistic regression model adjusted for four well-known risk factors (age, sex, body mass index and use of lipid-lowering drugs), we tested the association between each lipoprotein and the risk of UA. Combined with the result of LASSO and PLS-DA models, ten of them were identified as important LPs. The discrimination with the addition of selected LPs was evaluated. Compared with the basic logistic model that includes four risk factors, the addition of these ten LPs concentrations did not significantly improve UA versus NCA discrimination. However, thirty-two selected LPs showed notable discrimination power in logistic regression modeling distinguishing highGS UA patients from NCA with a 14.9% increase of the area under the receiver operating characteristics curve. Among these LPs, plasma from highGS patients was enriched with LDL and VLDL subfractions, but lacked HDL subfractions. In summary, we conclude that blood plasma lipoproteins can be used as biomarkers to distinguish UA patients with severe coronary lesions from NCA patients.

OriginalsprogEngelsk
Artikelnummer273
TidsskriftMetabolites
Vol/bind13
Udgave nummer2
Antal sider19
ISSN2218-1989
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This research was funded by the National Natural Science Foundation–Guangdong Joint Fund (No. U1801281) and Data + strategic project funding (the University of Copenhagen). Y.Y. was supported by the China Scholarship Council for one-year study at the University of Copenhagen.

Publisher Copyright:
© 2023 by the authors.

Citationsformater